January Therapeutics
Gary Schwartz is on the Board of Advisors at January Therapeutics. Gary is also the Division Chief, Hematology/Oncology & Deputy Director at Columbia University Irving Cancer Center.
This person is not in the org chart
This person is not in any offices
January Therapeutics
January Therapeutics is developing next generation targeted anti-cancer therapies. Building upon the finding that protein-based nano-formulations have led to substantial improvements in the efficacy of known drugs, January is developing unique chemical matter to leverage well established anti-cancer mechanisms of action while adding new cancer targeting properties.